3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
20
Papillomavirus Infections
12
Uterine Cervical Dysplasia
9
Condylomata Acuminata
7
Vulvar Neoplasms
4
Anus Neoplasms
4
Vaginal Neoplasms
3
Virus Diseases
1
Persistent Infection
1
Neoplasms
1
Neoplasm Metastasis
1
Inflammatory Bowel Diseases
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Crohn Disease
1
Colitis, Ulcerative
1
Cervical Cancer Screening
1
Acquired Immunodeficiency Syndrome
1
Interventions
Paclitaxel
28
Carboplatin
28
pembrolizumab
25
Bevacizumab
14
liposomal doxorubicin
12
Cisplatin
11
Gemcitabine
10
Radiotherapy
8
Drug Therapy
8
Cyclophosphamide
8
Blood Specimen Collection
8
Topotecan
7
Nivolumab
7
olaparib
6
Doxorubicin
6
niraparib
5
Therapeutics
5
Dexamethasone
5
pertuzumab
4
pazopanib
4
lenvatinib
4
fludarabine
4
cemiplimab
4
atezolizumab
4
Trastuzumab
4
Surveys and Questionnaires
4
Psychiatric Rehabilitation
4
Polymerase Chain Reaction
4
Fulvestrant
4
Docetaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Papillomavirus Vaccines
×
Gynecologic
×
Clear all
NCT06686043
2024-11-13
HPV-VIM
Baylor College of Medicine
Phase 2
Recruiting
85 enrolled